Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

Arch Gen Psychiatry. 2001 Oct;58(10):901-6. doi: 10.1001/archpsyc.58.10.901.

Abstract

Background: Although the popular drug 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") has been shown to damage brain serotonin (5-HT) neurons in animals, the fate and functional consequences of 5-HT neurons after MDMA injury are not known in humans. We investigated the long-term effects of MDMA use on cortical 5-HT neurons in humans and memory function, because brain 5-HT has been implicated in memory function.

Methods: Twenty-two recent MDMA users, 16 ex-MDMA users who had stopped using MDMA for more than 1 year, and 13 control subjects. The effects of MDMA use on cortical 5-HT neurons was studied by means of single-photon emission computed tomography with iodine 123-labeled 2beta-carbomethoxy-3beta-(4-iodophenyl) tropane ([(123)I]beta-CIT) by quantification of brain 5-HT transporter densities. Verbal memory performance was assessed with the Rey Auditory Verbal Learning Test.

Results: Mean cortical [(123)I]beta-CIT-labeled 5-HT transporter density was significantly lower in recent MDMA users than in controls (1.17 vs. 1.28 [-9%]) but not in ex-MDMA users (1.24 vs. 1.28 [-3%]). Recent and ex-MDMA users recalled significantly fewer words than did controls on the immediate recall (47.0 and 48.0 vs 60.0, respectively; P =.001) as well as the delayed recall (9.8 and 10.1 vs. 13.1, respectively; P =.003). Greater use of MDMA was associated with greater impairment in immediate verbal memory. However, memory performance was not associated with [(123)I]beta-CIT binding to cortical 5-HT transporters or duration of abstinence from MDMA.

Conclusion: The present study suggests that, while the neurotoxic effects of MDMA on 5-HT neurons in the human cortex may be reversible, the effects of MDMA on memory function may be long-lasting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain Chemistry / drug effects*
  • Carrier Proteins / analysis
  • Carrier Proteins / metabolism*
  • Cerebral Cortex / diagnostic imaging*
  • Cerebral Cortex / drug effects
  • Cocaine / analogs & derivatives
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Membrane Glycoproteins / analysis
  • Membrane Glycoproteins / metabolism*
  • Membrane Transport Proteins*
  • Memory Disorders / chemically induced
  • Memory Disorders / diagnosis*
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Nerve Tissue Proteins*
  • Neuropsychological Tests / statistics & numerical data
  • Neurotoxicity Syndromes / diagnostic imaging
  • Prognosis
  • Serotonin Plasma Membrane Transport Proteins
  • Substance-Related Disorders / diagnosis
  • Substance-Related Disorders / diagnostic imaging
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon / statistics & numerical data
  • Verbal Learning / drug effects

Substances

  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane
  • Cocaine
  • N-Methyl-3,4-methylenedioxyamphetamine